Skip to main content

Table 2. Laboratory results – Baseline and subgroup differentiation

From: Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study

  1. ATE/VTE Arterial/Venous Thromboembolism, ARDS Acute Respiratory Distress Syndrome, ECMO Extracorporeal Membrane-Oxygenation, INR International Normalized Ratio, aPTT Activated Partial Thromboplastin Time, PF1 + 2 Prothrombin Fragments 1 + 2, CRP C reactive protein